Parkinson’s UK/Rosetrees Trust Joint Senior Research FellowshipClosing Date: 19/01/2022
Support is provided for early career researchers to develop neuroprotective treatments for Parkinson’s through novel cell culture platforms.
Parkinson’s UK is a charitable organisation that provides a range of support measures and research funding to achieve its aim of finding a cure and improving the quality of life for everyone affected by Parkinson’s disease. Established in 1987 by a family business, Rosetrees Trust uses entrepreneurial philanthropy to fund medical researchers working across a broad range of illnesses to achieve improvements in human health.
Parkinson’s UK and Rosetrees Trust are jointly funding the Joint Senior Research Fellowship to support early career researchers with an excellent track record in novel cell culture techniques to establish a highly innovative independent drug discovery programme and become research leaders of the future.
Since their development, cell culture techniques have contributed to the understanding of disease processes and have played a vital role in drug discovery. However, in the past, traditional cell culture techniques have had some limitations. Recently, there have been a number of technological advances that have revolutionised cell culture systems. These include the development of patient derived cells and 3D culture systems. Such platforms have the potential to accelerate drug discovery in Parkinson’s.
With this fellowship scheme, the funders are keen to support the progression of neuroprotective treatments for Parkinson’s through the development and use of novel cell culture platforms.
|Funding body||Parkinson’s UK|
|Fund or call||Fund|